Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (63)

2024

  1. How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 442-452

  2. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

  3. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

2023

  1. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

  2. Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2

    Viruses, Vol. 15, Núm. 7

  3. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation, Vol. 107, Núm. 3, pp. 762-773

  4. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 222-235

2022

  1. Erratum: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies (Open Forum Infect Dis (2021) 8:6 DOI: 10.1093/ofid/ofab250)

    Open Forum Infectious Diseases

  2. Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 74, Núm. 5, pp. 757-765

2021

  1. COVID-19 in Solid Organ Transplant Recipients in Spain Throughout 2020: Catching the Wave?

    Transplantation, Vol. 105, Núm. 10, pp. 2146-2155

  2. COVID-19 in transplant recipients: The Spanish experience

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, Vol. 21, Núm. 5, pp. 1825-1837

  3. Early Stepdown from Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  4. Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a spanish multicenter cohort

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 5

  5. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

    Transplant infectious disease : an official journal of the Transplantation Society, Vol. 23, Núm. 3, pp. e13520

  6. IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 5, pp. 1652-1661.e1

  7. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

  8. Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

    Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35

  9. Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation

    The Journal of infectious diseases, Vol. 223, Núm. 7, pp. 1205-1213

  10. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

  11. Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study

    PLoS ONE, Vol. 16, Núm. 4 April